Razelle Kurzrock/froedtert.com
Jan 26, 2025, 21:55
Razelle Kurzrock: Target Cancer National Molecular Tumor Board
Razelle Kurzrock, Founding Director at Michels Rare Cancers Research Laboratories shared a post on X:
“Target Cancer National Molecular Tumor Board. Bringing together experts across the country for the TRACK national precision medicine trial for rare cancers.
Thank you to an incredible group who give their time to help find solutions for patients with rare cancers.”
More posts featuring Razelle Kurzrock.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 3, 2025, 03:25
Jun 2, 2025, 18:07
Jun 2, 2025, 18:00
Jun 2, 2025, 17:43
Jun 2, 2025, 17:18
Jun 2, 2025, 17:06